What you should know:
1. Dr. Bundschu was part of the nine-physician team behind the study.
2. The cohort studied Nevro’s HF10 technology.
3. This was the first large-scale observational study on the effectiveness of HF10 spinal cord stimulation technology.
More articles on orthopedics:
Legislation, bundled payments may be stabilizing neurosurgery reimbursement
Indiana spine, neurosurgeon group refuses to become employed at IU Health, jeopardizing relationships: 5 details
Stryker aims to make a new spine acquisition in the next 6 months, K2M integration on track
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
